These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 7906412)
41. Cancer cachexia is transmissible in plasma. Illig KA; Maronian N; Peacock JL J Surg Res; 1992 Apr; 52(4):353-8. PubMed ID: 1593873 [TBL] [Abstract][Full Text] [Related]
42. Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model. Busquets S; Castillejo M; Jové Q; Jude B; Mejías P; López-Soriano FJ; Argilés JM Onco Targets Ther; 2021; 14():1953-1959. PubMed ID: 33762827 [TBL] [Abstract][Full Text] [Related]
43. Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats. Salazar-Degracia A; Busquets S; Argilés JM; López-Soriano FJ; Barreiro E PeerJ; 2017; 5():e4109. PubMed ID: 29255650 [TBL] [Abstract][Full Text] [Related]
44. Reversal of cancer cachexia in rats by cimaterol and supplemental nutrition. Stallion A; Zhang FS; Chance WT; Foley-Nelson T; Fischer JE Surgery; 1991 Oct; 110(4):678-84. PubMed ID: 1681593 [TBL] [Abstract][Full Text] [Related]
45. Anticatabolic effect of the beta 2-agonist cimaterol in vivo in tumor-bearing animals. Stallion A; Foley-Nelson T; Chance WT; James JH; Fischer JE J Surg Res; 1995 Sep; 59(3):387-92. PubMed ID: 7643598 [TBL] [Abstract][Full Text] [Related]
46. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor. Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441 [TBL] [Abstract][Full Text] [Related]
47. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031 [TBL] [Abstract][Full Text] [Related]
48. Effects of increased beta 2-agonist dose in tumor-bearing animals. Stallion A; Foley-Nelson T; Chance WT; Fischer JE Nutr Cancer; 1993; 20(3):251-60. PubMed ID: 7906412 [TBL] [Abstract][Full Text] [Related]